文献速递神经免疫

尼古丁、饮酒与重症肌无力风险:瑞典全国GEMG研究

Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the Swedish Nationwide GEMG Study.
PubMed 文献 · Neurology · 2025-06-10

该研究基于瑞典全国病例对照GEMG研究,纳入1,067例重症肌无力(MG)患者与2,087名匹配对照,评估饮酒、吸烟及瑞典鼻烟与MG风险的关联。结果显示,任何饮酒与MG风险降低相关(OR 0.48),而发病时吸烟或使用瑞典鼻烟与早发型MG风险升高相关。

要点

  • 任何饮酒与MG风险降低相关(OR 0.48,95%CI 0.39-0.59,p<0.001)。
  • 发病时吸烟与早发型MG风险升高相关(OR 1.60,95%CI 1.17-2.20,p=0.003)。
  • 发病时使用瑞典鼻烟与早发型MG风险升高相关(OR 1.61,95%CI 1.02-2.54,p=0.039)。

核心结论

  • 饮酒与MG风险呈负相关,而发病时吸烟或使用瑞典鼻烟与早发型MG风险升高相关。

研究设计与样本

  • 瑞典全国性横断面病例对照研究(GEMG研究),纳入1,067例MG患者和2,087名按性别和出生年份匹配的对照。

主要发现

  • 任何饮酒与MG风险降低相关(OR 0.48,95%CI 0.39-0.59,p<0.001,暴露病例n=616)。
  • 吸烟与早发型MG风险升高相关(OR 1.60,95%CI 1.17-2.20,p=0.003,n=133),在乙酰胆碱受体抗体阳性早发型MG中更显著(OR 2.08,95%CI 1.34-3.25,p=0.001,n=74)。
  • 使用瑞典鼻烟与早发型MG风险升高相关(OR 1.61,95%CI 1.02-2.54,p=0.039,n=43)。

临床怎么用

  • 临床评估MG风险时,可询问饮酒、吸烟及鼻烟使用情况,尤其对早发型MG可疑患者。

局限性

  • 回顾性数据可能存在回忆偏倚,且可用对照数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Myasthenia gravis (MG), an autoimmune disease characterized by fluctuating muscle weakness, is believed to result from complex gene-environment interactions, yet few risk factors have been identified. The objective of this study was to determine the effect of nicotine and alcohol on MG disease risk. METHODS: The Genes and Environment in Myasthenia Gravis study is a Swedish, nationwide cross-sectional case-control study where prevalent patients with MG were invited to submit an extensive questionnaire on lifestyle and environment. Data collection took place between November 2018 and August 2019, and cases were matched by sex and year of birth to population controls. Year of disease onset was used as index year. Associations between use of alcohol, tobacco smoke, Swedish snuff, and MG risk were investigated using multivariable logistic regression. RESULTS: A total of 1,067 patients with MG (mean age at onset 48 (SD 21) years, 53% female) were matched to 2,087 controls. Any alcohol consumption was associated with a lower MG risk compared with not drinking at all (odds ratio [OR] 0.48, 95% CI 0.39-0.59, p < 0.001, exposed cases n = 616). Effects were observed in a similar direction across disease subtypes, with the strongest association in the late-onset MG group (onset ≥50 years). Although neither cigarette smoke nor use of Swedish snuff affected the disease risk of the whole group, subset specific effects were observed. Smoking at onset was associated with an increased risk of early-onset MG (EOMG, onset 18-49 years; OR 1.60, 95% CI 1.17-2.20, p = 0.003, n = 133), which was accentuated in acetylcholine receptor antibody-positive EOMG (OR 2.08, 95% CI 1.34-3.25, p = 0.001, n = 74). Use of Swedish snuff, which contains high levels of nicotine, at disease onset was also associated with an increased risk of EOMG (OR 1.61, 95% CI 1.02-2.54, p = 0.039, n = 43). DISCUSSION: We observed an inverse correlation of MG risk and alcohol consumption. Furthermore, smoking and the use of Swedish snuff at disease onset were positively associated with EOMG. We recognize limitations related to retrospective data and limited number of available controls. However, multiple sensitivity analyses were performed supporting the robustness of our results.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Petersson M, Jons D, Feresiadou A, et al. Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the Swedish Nationwide GEMG Study. Neurology. 2025. PMID: 40493875. doi:10.1212/WNL.0000000000213771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。